International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease
Nature Reviews Endocrinology
May 2025
Aleksova J.
Raloxifene in the Treatment of Osteoporosis in Postmenopausal Women with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
Hormone and Metabolic Research
1 November 2021
Ma H.Y.
Open Access
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D
Cochrane Database of Systematic Reviews
7 July 2021
Hara T.
All Open Access, Green
Fractures in patients with chronic kidney disease
Ukrainian Journal of Nephrology and Dialysis
2021
Dudar S.L.
Open Access
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
October 2020
Bar M.
Open Access
Effectiveness of antiresorptive medications in women on long-term dialysis after hip fracture: A population-based cohort study
Plos One
September 2020
Lin Y.C.
Open Access
Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis
Current Osteoporosis Reports
1 December 2018
Aleksova J.
Diabetes and Bone Disease
Endocrinology and Metabolism Clinics of North America
1 March 2017
Schacter G.I.
Efficacy of Osteoporosis Therapies in Diabetic Patients
Calcified Tissue International
1 February 2017
Schwartz A.V.
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease
Kidney International
1 January 2016
Newman C.L.
Open Access
Mechanism for the development of bone disease in diabetes: Renal bone disease
Musculoskeletal Disease Associated with Diabetes Mellitus
1 January 2016
Imanishi Y.
The prevention of fragility fractures in diabetic patients
Aging Clinical and Experimental Research
April 2015
Gonnelli S.
Effect of raloxifene on parathyroid hormone in Osteopenic and Osteoporotic postmenopausal women with chronic kidney disease stage 5
Iranian Journal of Kidney Diseases
1 November 2014
Haghverdi F.
Medicinsk behandling af osteoporose hos patienter med moderat til svært nedsat nyrefunktion
Ugeskrift for Laeger
2012
Eiken P.A.
Significant effect of raloxifene on bone in hemodialysis patients
International Journal of Endocrinology and Metabolism
2012
Ravn P.
Open Access
Raloxifene may have further benefits in women on hemodialysis
International Journal of Endocrinology and Metabolism
2012
Worsley R.
Open Access
Raloxifene in Hemodialysis Patients
International Journal of Endocrinology and Metabolism
June 2012
Keller F.
Open Access
Effects of raloxifene on bone in patients with type 2 diabetes
International Journal of Endocrinology and Metabolism
2012
Gorai I.
Open Access
Are physicians ready to prevent osteoporotic fractures in hemodialysis patients?
International Journal of Endocrinology and Metabolism
2012
Lasco A.
Open Access
Safety of raloxifene in hemodialysis patients
International Journal of Endocrinology and Metabolism
2012
Jacobsen D.
Open Access
Effects of raloxifene on bone metabolism in hemodialysis patients
International Journal of Endocrinology and Metabolism
June 2012
Iwamoto J.
Open Access
Which method is more efficient in determining osteoporosis, QUS or DEXA?
International Journal of Endocrinology and Metabolism
2012
Dane C.
Open Access
Preventing fractures in diabetic dialysis patients
International Journal of Endocrinology and Metabolism
2012
Lewiecki E.M.
Open Access
Oxidative Stress and Raloxifene
International Journal of Endocrinology and Metabolism
June 2012
Akgol G.
Open Access